Val158Met Polymorphism in the Catechol-O-Methyltransferase (COMT) Gene Is Not Associated with Tardive Dyskinesia in Schizophrenia
Authors:
- Seung-Gul KangSeung-Gul Kang
- Jung-Eun ChoiJCJung-Eun Choi
- Young-Min ParkYPYoung-Min Park
- Heon-Jeong LeeHLHeon-Jeong Lee
- Changsu HanCHChangsu Han
- Yong-Ku KimYKYong-Ku Kim
- Seung-Hyun KimSKSeung-Hyun Kim
- Min-Soo LeeMLMin-Soo Lee
- Sook-Haeng JoeSJSook-Haeng Joe
- In-Kwa JungIJIn-Kwa Jung
- Leen KimLKLeen Kim
- 18 April 2008
- journal article
- Published by S. Karger AG in Neuropsychobiology
- Vol. 57 (1-2) , 22-25
Abstract
Objective: This study investigated whether the catechol-O-methyltransferase (COMT) gene V158M single-nucleotide polymorphism (SNP) influences susceptibility to tardive dyskinesia (TD). Methods: We examined 209 Korean schizophrenic patients using the Abnormal Involuntary Movement Scale (AIMS), with genotyping performed for the COMT gene V158M SNP. Results: The logistic regression analysis showed that old age [p = 0.032, OR = 1.40 (OR corresponds to 10-year), 95% CI = 1.03–1.90] was a risk factor for TD, but there was no significant association between the COMT genotype and TD. The heterozygotes (MV genotype) of the COMT gene polymorphism tended to develop TD less than homozygotes (MM and VV); however, the risk did not reach statistical significance (p = 0.050, OR = 1.81, 95% CI = 1.00–3.29). Conclusions: These results suggest that the V158M SNP of the COMT gene is not associated with TD in schizophrenia. However, there is a tendency that the heterozygous genotype of the COMT gene polymorphism has a protective effect against TD. Further investigations are warranted to evaluate a molecular heterosis of this polymorphism in development of TD in a large sample of subjects.Keywords
This publication has 25 references indexed in Scilit:
- No evidence for an association between G protein β3 subunit gene C825T polymorphism and tardive dyskinesia in schizophreniaHuman Psychopharmacology: Clinical and Experimental, 2007
- Negative association between Catechol-O-methyltransferase (COMT) gene Val158Met polymorphism and persistent tardive dyskinesia in schizophreniaJournal of Neural Transmission, 2004
- COMT
val
158
met
Genotype Affects µ-Opioid Neurotransmitter Responses to a Pain StressorScience, 2003
- Familial occurrence of tardive dyskinesiaActa Psychiatrica Scandinavica, 2001
- Aggressive behaviour in patients with schizophrenia is associated with catechol-O-methyltransferase genotypeThe British Journal of Psychiatry, 2001
- Molecular Heterosis: A ReviewMolecular Genetics and Metabolism, 2000
- The current status of tardive dyskinesiaAustralian & New Zealand Journal of Psychiatry, 2000
- Pharmacological Options for the Management of DyskinesiasDrugs, 1996
- Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disordersPharmacogenetics, 1996
- Kinetics of Human Soluble and Membrane-Bound Catechol O-Methyltransferase: A Revised Mechanism and Description of the Thermolabile Variant of the EnzymeBiochemistry, 1995